Guidet, Bertrand http://orcid.org/0000-0002-7643-6770
,
de Lange, Dylan W.
Boumendil, Ariane
Leaver, Susannah
Watson, Ximena
Boulanger, Carol
Szczeklik, Wojciech
Artigas, Antonio
Morandi, Alessandro
Andersen, Finn
Zafeiridis, Tilemachos
Jung, Christian
Moreno, Rui
Walther, Sten
Oeyen, Sandra
Schefold, Joerg C.
Cecconi, Maurizio
Marsh, Brian
Joannidis, Michael
Nalapko, Yuriy
Elhadi, Muhammed
Fjølner, Jesper
Flaatten, Hans
Article History
Received: 12 August 2019
Accepted: 1 November 2019
First Online: 29 November 2019
Compliance with ethical standards
:
: Joerg C. Schefold declares that the Dept. of Intensive Care Medicine Bern has/had research and/or development/consulting contracts with (full disclosure): Orion Corporation, Abbott Nutrition International, B. Braun Medical AG, CSEM SA, Edwards Lifesciences Services GmbH/SA, Kenta Biotech Ltd, Maquet Critical Care AB, Omnicare Clinical Research AG, and Nestlé. Educational grants were received from Fresenius Kabi; GSK; MSD; Lilly; Baxter; Astellas; AstraZeneca; B. Braun Medical AG, CSL Behring, Maquet, Novartis, Covidien, Nycomed, Pierre Fabre Pharma (Roba Pharma); Pfizer, Orion Pharma. The money went into departmental funds. No personal financial gain applies. All other authors do not have any conflict of interest to declare related to this manuscript.
Free to read: This content has been made available to all.